FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 99 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,063,000 | – | 502,177 | +8369516.7% | 0.03% | – |
| Q1 2020 | $0 | -100.0% | 6 | -100.0% | 0.00% | -100.0% |
| Q2 2018 | $1,265,000 | -7.9% | 80,000 | 0.0% | 0.02% | -13.0% |
| Q1 2018 | $1,374,000 | -21.7% | 80,000 | 0.0% | 0.02% | -23.3% |
| Q4 2017 | $1,754,000 | -14.3% | 80,000 | +60.0% | 0.03% | -16.7% |
| Q3 2017 | $2,046,000 | +15.1% | 50,000 | -15.3% | 0.04% | +9.1% |
| Q2 2017 | $1,777,000 | +53.6% | 59,000 | +84.4% | 0.03% | +50.0% |
| Q1 2017 | $1,157,000 | -27.8% | 32,000 | 0.0% | 0.02% | -40.5% |
| Q4 2016 | $1,603,000 | +27.2% | 32,000 | +33.3% | 0.04% | +23.3% |
| Q3 2016 | $1,260,000 | +12.8% | 24,000 | -11.1% | 0.03% | +3.4% |
| Q2 2016 | $1,117,000 | -23.2% | 27,000 | -25.0% | 0.03% | -19.4% |
| Q1 2016 | $1,455,000 | -68.5% | 36,000 | -67.7% | 0.04% | -71.0% |
| Q4 2015 | $4,619,000 | +208.3% | 111,300 | +14.4% | 0.12% | +235.1% |
| Q3 2015 | $1,498,000 | – | 97,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|